Results
|
501.
|
|
|
502.
|
|
|
503.
|
|
|
504.
|
|
|
505.
|
Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. [electronic resource] by
- Jacobson, M A
- Wulfsohn, M
- Feinberg, J E
- Davis, R
- Power, M
- Owens, S
- Causey, D
- Heath-Chiozzi, M E
- Murphy, R L
- Cheung, T W
Producer: 19940726
In:
AIDS (London, England) vol. 8
Availability: No items available.
|
|
506.
|
Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir. [electronic resource] by
- Mueller, A J
- Jacobson, M A
- Hurwitz, S
- Chuang, E L
- Friedberg, D N
- Haidt, S J
- Heinemann, M H
- Jabs, D A
- Kaplan, H J
- Freeman, W R
Producer: 19970513
In:
AIDS (London, England) vol. 11
Availability: No items available.
|
|
507.
|
|
|
508.
|
|
|
509.
|
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. [electronic resource] by
- Bibert, Stéphanie
- Wojtowicz, Agnieszka
- Taffé, Patrick
- Manuel, Oriol
- Bernasconi, Enos
- Furrer, Hansjakob
- Günthard, Huldrych F
- Hoffmann, Matthias
- Kaiser, Laurent
- Osthoff, Michael
- Cavassini, Matthias
- Bochud, Pierre-Yves
Producer: 20150601
In:
AIDS (London, England) vol. 28
Availability: No items available.
|
|
510.
|
|
|
511.
|
|
|
512.
|
|
|
513.
|
|
|
514.
|
|
|
515.
|
|
|
516.
|
|
|
517.
|
|
|
518.
|
|
|
519.
|
|
|
520.
|
|